BetterLife Pharma Inc.
BETR
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.30K | 5.70K | 16.00K | 13.70K | 5.70K |
| Total Receivables | 2.10K | 8.30K | 6.60K | 5.90K | 8.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 150.70K | 193.80K | 143.10K | 147.70K | 141.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 162.10K | 207.70K | 165.70K | 167.40K | 155.40K |
|
|
|||||
| Total Current Assets | 162.10K | 207.70K | 165.70K | 167.40K | 155.40K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 400.00 | -- |
| Total Assets | 162.10K | 207.70K | 165.70K | 167.80K | 155.40K |
|
|
|||||
| Total Accounts Payable | 2.91M | 2.81M | 2.79M | 2.83M | 3.11M |
| Total Accrued Expenses | 974.80K | 869.50K | 613.20K | 591.60K | 738.20K |
| Short-term Debt | 382.00K | 269.40K | 269.00K | -- | 282.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 265.10K | 201.20K | 225.60K | 629.90K | 601.50K |
| Total Finance Division Other Current Liabilities | 389.20K | 391.90K | 432.70K | 480.60K | 480.50K |
| Total Other Current Liabilities | 389.20K | 391.90K | 432.70K | 480.60K | 480.50K |
| Total Current Liabilities | 4.92M | 4.54M | 4.33M | 4.53M | 5.21M |
|
|
|||||
| Total Current Liabilities | 4.92M | 4.54M | 4.33M | 4.53M | 5.21M |
| Long-Term Debt | 20.00K | 68.50K | 38.70K | 37.10K | 33.90K |
| Short-term Debt | 382.00K | 269.40K | 269.00K | -- | 282.10K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.94M | 4.61M | 4.36M | 4.57M | 5.24M |
|
|
|||||
| Common Stock & APIC | 60.43M | 58.49M | 59.22M | 58.91M | 55.25M |
| Retained Earnings | -88.54M | -85.42M | -86.20M | -85.98M | -81.94M |
| Treasury Stock & Other | 20.90M | 20.18M | 20.39M | 20.27M | 19.31M |
| Total Common Equity | -7.21M | -6.75M | -6.59M | -6.81M | -7.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.21M | -6.75M | -6.59M | -6.81M | -7.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.43M | 2.35M | 2.39M | 2.40M | 2.29M |
| Total Equity | -4.78M | -4.40M | -4.20M | -4.40M | -5.09M |
|
|
|||||